Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Italy Fines Apple €98.6 Million Over App Store Dominance 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
GREELEY, Colo., Oct. 20, 2016 -- JBS USA will hold its third quarter 2016 earnings conference call on Thursday, November 17, 2016, at 9:00 a.m. Eastern (7:00 a.m. Mountain). The call will be open to investors in the Company’s bonds and term loan, as well as lenders to the Company’s revolving credit facility and prospective investors, securities analysts and market makers. More information about the call will be posted to the Company’s website at www.jbssa.com. On the website, please go to the “Investors” page and select the “JBS USA bond investors” link. Financial statements and related data for the third quarter 2016 will be made available to investors on the Company’s website prior to the call.
JBS USA is a leading processor of beef and pork in the United States, the number one processor of beef in Australia in terms of daily slaughtering capacity, and the number two U.S. processor of chicken through its subsidiary, Pilgrim’s Pride Corporation. The Company processes, prepares, packages and delivers fresh, processed and value-added beef, pork, chicken, and lamb products for sale to customers in the United States and international markets. In addition to the U.S. and Australia, the Company has processing facilities in Canada (beef) and Mexico (chicken). The Company is an indirect wholly owned subsidiary of JBS S.A., the world’s largest animal protein producer.
CONTACT: Dunham Winoto Director, Investor Relations [email protected] 970-506-8192 Web site: http://www.jbssa.com/
